
About Abegaill
Abegaill is a company based in Rotterdam (Netherlands) founded in 2017. It operates as a HealthTech. Abegaill offers products and services including Ductoscopy Devices. Abegaill operates in a competitive market with competitors including Cianna Medical, Elucent Medical, KUB Technologies, SenoRx and Health Beacons, among others.
- Headquarter Rotterdam, Netherlands
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website abegaill.com
- Legal Name Abegaill B.V.
- InvestorsSwanbridge Capital
& 1 more
Products & Services of Abegaill
Abegaill offers a comprehensive portfolio of products and services, including Ductoscopy Devices.
Devices for ductoscopy to treat breast disease are developed.
Funding Insights of Abegaill
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Abegaill with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2017 | – | Seed | β | Swanbridge Capital, Leander Healthcare | β |
2 investors in total: 2 institutional.
Investors in Abegaill
Abegaill has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Swanbridge Capital and Leander Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | swanbridgecapital.nl | - | |
Leander Healthcare is engaged in distributing medical devices in Benelux. | 2009 | leanderhealthcare.com | Vleuten, Netherlands |
Investor details for Abegaill
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Abegaill
1 people are tracked at Abegaill (1 in leadership).
| Name | Role | Group |
|---|---|---|
Edwin Leander | CEO | Leadership |
Complete people profiles for Abegaill
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Abegaill
2 dated milestones of Abegaill, from founding to its latest funding, stage changes and deals.
- Founded Abegaill is founded.
- Funding First funding round.
Competitors of Abegaill
Abegaill operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cianna Medical, Elucent Medical, KUB Technologies, SenoRx and Health Beacons, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ciannamedical.com | 2007 | Aliso Viejo, United States | $49.5M | 2,709 | Breast brachytherapy devices and surgical guidance systems are developed. | |
| elucentmedical.com | 2014 | Brookfield, United States | – | 11 | Develops smart surgical guidance systems with in-body spatial intelligence for accuracy. | |
| kubtec.com | 2005 | Stratford, United States | – | 51 | Provides medical devices for specimen imaging and gamma probes in healthcare facilities. | |
| senorx.com | 1998 | Irvine, United States | – | – | Minimally Invasive devices for breast cancer treatment & diagnosis | |
| healthbeacons.com | 2008 | Concord, United States | – | 4,165 | Provides an RFID localization system for effective cancer treatment. | |
| polumiros.com | 2016 | Toronto, Canada | – | – | Regenerative biomaterials for immunomodulatory tissue healing are developed. | |
| rogerssciences.com | 2010 | Boston, United States | $500,000 | – | Offers continuous low irradiance photodynamic therapy for breast cancer treatment. | |
| medi-future.com | 2006 | Seongnam-si, South Korea | – | – | Medical devices for breast diagnostics and bone care are produced. | |
| scionmedtech.com | 2011 | Shanghai, China | – | – | Creates innovative technologies for breast biopsy devices. |
Detailed competitors of Abegaill
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Abegaill
10 companies that operate in the same segment as Abegaill (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abegaill
Abegaill was founded in 2017.
Abegaill is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.
Edwin Leander is the current CEO of Abegaill.
Abegaill B.V. is engaged in the development of medical devices specialized in ductoscopy. The company is aimed at treating pre-malignant and malignant breast diseases through innovative solutions. Based in Rotterdam, Netherlands, it operates within the healthcare sector, focusing on advancing diagnostic and treatment technologies for breast health.
Abegaill's top competitors include Cianna Medical, SenoRx and Polumiros.
Abegaill offers Ductoscopy Devices.
Abegaill has 2 investors. Key investors include Swanbridge Capital, and Leander Healthcare.
Abegaill operates through Abegaill B.V..